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Sir,
We reported the unambiguous presence of human papilloma
virus (HPV) type 18 and HPV-associated koilocytes in breast
cancers that had occurred in Australian women (Heng et al, 2009;
Lawson et al, 2009). Koilocytes are epithelial cells characterised by
perinuclear haloes surrounding condensed nuclei and are specifi-
cally associated with HPV infections and early oncogenic processes.
Sandstrom (2010) has made several interesting and important
comments about these reports, namely: (i) he and his colleagues
had previously made similar observations of HPV-associated
koilocytes in breast cancer cases; (ii) Sarkola et al (2008) had
identified HPV 16 in 4% of 223 human breast milk samples in
Finland; and (iii) Cazzaniga et al (2009) had identified HPV of
multiple types in 14% of 90 breast ductal lavages, HPV 16 in one of
10 breast colostrum samples, and HPV 5 and 23 in two of 25 breast
milk samples in Italy.
We have also identified high-risk HPV (type 16) in human
breast milk from normal unselected women. We used standard and
in situ PCR techniques with identical primers and methods as
reported in Heng et al (2009) to seek to identify HPV in breast
milk. Using standard PCR, we screened DNA extracted from 24
samples of human breast milk from unselected normal (no history
of breast cancer) women. Two (8.3%) were positive, both of whom
were HPV type 16 as demonstrated by automated sequencing. In a
different set of milk samples, using in situ PCR, we demonstrated
HPV 16 in the nuclei of epithelial cells of one sample. This latter
observation indicated that the outcomes based on standard PCR
were unlikely to be due to contamination.
The implication of these various observations, including the
identification of high-risk HPV in the Australian milk samples, is
suggestive of a possible causal role of high-risk HPV in some
breast cancers.
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